Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 6, June, p. 743–748

doi: 10.17219/acem/69227

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Lost life years due to premature mortality caused by diseases of the respiratory system

Irena Maniecka-Bryła1,A,F, Paulina Paciej-Gołębiowska1,C,D, Elżbieta Dziankowska-Zaborszczyk1,B, Marek Bryła2,E

1 Department of Epidemiology and Biostatistics, Medical University of Lodz, Poland

2 Department of Social Medicine, Medical University of Lodz, Poland

Abstract

Background. In Poland, as in most other European countries, diseases of the respiratory system are the 4th leading cause of mortality; they are responsible for about 8% of all deaths in the European Union (EU) annually. To assess the socio-economic aspects of mortality, it has become increasingly common to apply potential measures rather than conventionally used ratios.
Objectives. The aim of this study was to analyze years of life lost due to premature deaths caused by diseases of the respiratory system in Poland from 1999 to 2013.
Material and Methods. The study was based on a dataset of 5,606,516 records, obtained from the death certificates of Polish residents who died between 1999 and 2013. The information on deaths caused by diseases of the respiratory system, i.e., coded as J00–J99 according to the International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10), was analyzed. The Standard Expected Years of Life Lost (SEYLL) indicator was used in the study.
Results. In the years 1999–2013, the Polish population suffered 280,519 deaths caused by diseases of the respiratory system (4.69% of all deaths). In the period analyzed, a gradual decrease in the standardized death rate was observed – from 46.31 per 100,000 inhabitants in 1999 to 41.02 in 2013. The dominant causes of death were influenza and pneumonia (J09–J18) and chronic lower respiratory diseases (J40–J47). Diseases of the respiratory system were the cause of 4,474,548.92 lost life years. The Standard Expected Years of Life Lost per person (SEYLLp) was 104.72 per 10,000 males and 52.85 per 10,000 females. The Standard Expected Years of Life Lost per death (SEYLLd) for people who died due to diseases of the respiratory system was 17.54 years of life on average for men and 13.65 years on average for women.
Conclusion. The use of the SEYLL indicator provided significant information on premature mortality due to diseases of the respiratory system, indicating the fact that they play a large role in the health status of the Polish population.

Key words

years of life lost, premature mortality, respiratory system, Poland

References (22)

  1. Statistical Office of the European Communities. Respiratory diseases statistics. Eurostat: statistics explained. http://ec.europa.eu/eurostat/statistics-explained/index.php/Respira-tory_diseases_statistics. Published October, 2016. Updated December 16, 2016. Accessed December 20, 2016.
  2. Dmochowska H, ed. Statistical Yearbook of the Republic of Poland 2015. Warszawa: Central Statistical Office; 2015.
  3. World Health Organization. World Health Statistics Report 2008. http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf. Accessed December 20, 2016.
  4. World Health Organization Regional Office for Europe. European health for all database. http://data.euro.who.int/hfadb/. Published 2002. Updated June, 2016. Accessed December 20, 2016.
  5. Murray CJL, Lopez AD. The Global Burden of Disease. A comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2010. Boston, MA: Harvard University Press; 1996.
  6. Marshall RJ. Standard Expected Years of Life Lost as a measure of disease burden: An investigation of its presentation, meaning and interpretation. In: Preedy VR, Watson RR, eds. Handbook of Disease Burdens and Quality of Life Measures. Berlin: Springer; 2009:3421–3434.
  7. Selb Semerl J, Sesok J. Years of potential life lost and valued years of potential life lost in assessing premature mortality in Slovenia. CMJ. 2002;43:439–445.
  8. Santric Milicevic M, Bjegovic V, Terzic Z, et al. Serbia within the European context: An analysis of premature mortality. Popul Health Metr. 2009;7:12.
  9. Supplement to: Murray CJL, Ezzati M, Flaxman AD, et al. GBD 2010: Design, definitions, and metrics. Lancet. 2012;380:2063–2066.
  10. Office for National Statistics. Deaths registered in England and Wales: 2015. http://ons.gov.uk. Published July, 2016. Accessed December 20, 2016.
  11. Preaud EDL, Macabeo B, Farkas N, et al. Annual public health and economic benefits of seasonal influenza vaccination: A European estimate. BMC Public Health. 2014;14:813.
  12. Council of the European Communities. Proposal for a Council Recommendation on Seasonal Influenza Vaccination. Brussels; 2009.
  13. Raise Awareness of Influenza Strategies in Europe. Szczepienia przeciw grypie: podstawowe fakty dla lekarzy pierwszego kontaktu w Europie. Warszawa; 2016.
  14. Kolegium Lekarzy Rodzinnych w Polsce. Profilaktyka i leczenie grypy. Łódź; 2006.
  15. Ogólnopolski Program Zwalczania Grypy. Raport. Ernst & Young. http://instytutoz.org/wp-content/uploads/2013/12/Raport_II_Ogolnopolski_Program_Zwalczania_Grypy.pdf. Published June, 2013. Accessed December 20, 2016.
  16. Polish Ministry of Health. Komunikat Głównego Inspektora Sanitarnego w sprawie Programu Szczepień Ochronnych na rok 2016. Warszawa: Dziennik Urzędowy Ministra Zdrowia; 2016.
  17. Subbarao P, Mandhane PJ, Sears MR. Asthma: Epidemiology, etiology and risk factors. CMAJ. 2009;181(9):E181–E190.
  18. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;6(176):532–555.
  19. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis. 2009;4:137–148.
  20. Maniecka-Bryła I, Bryła M, Bryła P, et al. The burden of premature mortality in Poland analysed with the use of standard expected years of life lost. BMC Public Health. 2015;15:101.
  21. Gènova-Maleras R, Catalá-López F, de Larrea-Baz NF, et al. The burden of premature mortality in Spain using standard expected years of life lost: A population-based study. BMC Public Health. 2011;11:787.
  22. Burnet NG, Jefferies SJ, Benson RJ, et al. Years of life lost (YLL) from cancer is an important measure of population burden – and should be considered when allocating research funds. Brit J Cancer. 2005;92(2):241–245.
© Wroclaw Medical University